TransMedics Group: I Estimate A Large Upside By The End Of 2028 [Seeking Alpha]
TransMedics Group, Inc. (TMDX)
Last transmedics group, inc. earnings: 3/2 04:05 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
I estimate 2028 revenue at $1.35 billion, driven by achieving 10k transplants at a $105,000 average price, plus $300 million in additional revenue. Net income margin is now forecast at 17.5% for 2028, with long-term potential to exceed 20%, as seen in peer medical device companies. Thitima Uthaiburom/iStock via Getty Images The TransMedics Investment Thesis TransMedics Group, Inc. TMDX ) is one of the companies in my portfolio that I believe has enormous upside potential. TransMedics' technology has the potential to transform transplant procedures in the long term and save lives. However, I also This article was written by Analyst's Disclosure: I/we have a beneficial long position in the shares of TMDX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in
Show less
Read more
Impact Snapshot
Event Time:
TMDX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TMDX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TMDX alerts
High impacting TransMedics Group, Inc. news events
Weekly update
A roundup of the hottest topics
TMDX
News
- Why TransMedics Group, Inc. (NASDAQ:TMDX) Looks Like A Quality Company [Yahoo! Finance]Yahoo! Finance
- TransMedics: A Stagnant Monopoly Facing Regulatory Pressure [Seeking Alpha]Seeking Alpha
- TransMedics Group (NASDAQ:TMDX) had its "overweight" rating reaffirmed by analysts at Piper Sandler.MarketBeat
- TransMedics Group (NASDAQ:TMDX) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=TMDX&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall StreeMarketBeat
- TransMedics Group (NASDAQ:TMDX) had its price target raised by analysts at Canaccord Genuity Group Inc. from $147.00 to $148.00. They now have a "buy" rating on the stock.MarketBeat
TMDX
Earnings
- 10/29/25 - Beat
TMDX
Sec Filings
- 12/5/25 - Form 4
- 12/5/25 - Form 4
- 12/3/25 - Form 144
- TMDX's page on the SEC website